Ophthalmology Times Newsletter

To view this email as a web page, click here.

First treatment for NMOSD receives FDA approval

Eculizumab (Soliris, Alexion) has been cleared by the U.S. Food and Drug Administration to treat neuromyelitis optica spectrum disorder (NMOSD) in adults with a specific biomarker.

Learn more

Cataract surgery in uveitic glaucoma eye can have good result

Patients with uveitic glaucoma have diverse presentations. Carefully planned cataract surgery can be successful, according to Mark A. Werner, MD.

Find out

Macular Degeneration Association unveils AMD Centers of Excellence

Technology assisting surgeons in capturing spectral-domain OCT

DMEK vs. DSAEK: Debate goes on

Tips to improve diversity, excellence in recruiting ophthalmology faculty

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.